设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
CNKI学位论文(2)
知网期刊论文(2)
在“
Elsevier电子期刊
”中,
命中:
25
条,耗时:小于0.01 秒
在所有数据库中总计命中:
4
条
1.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial
作者:
Prof Christoph Zielinski
;
MD
a
;
christoph.zielinski@meduniwien.ac.at" class="auth_mail" title="E-mail the corresponding author
;
Prof Istvá
;
n Lá
;
ng
;
MD
b
;
Prof Moshe Inbar
;
MD
c
;
Prof Zsuzsanna Kahá
n ;
MD
d
;
Prof Richard Greil
;
MD
e
;
Prof Semir Beslija
;
MD
f
;
Salomon M Stemmer
;
MD
g
;
Zanete Zvirbule
;
MD
h
;
Gü
;
nther G Steger
;
MD
a
;
Prof
Bohuslav
Melichar
;
MD
i
;
Tadeusz Pienkowski
;
MD
j
;
Daniela Sirbu
;
MD
k
;
Prof Lubo&scaron
;
Petruzelka
;
MD
l
;
Alexandru Eniu
;
MD
m
;
Bella Nisenbaum
;
MD
n
;
Prof Magdalena Dank
;
MD
o
;
Prof Rodica Anghel
;
MD
p
;
Diethelm Messinger
;
MSc
q
;
Thomas Brodowicz
;
MD
a
;
for the TURANDOT investigators
&dagger
;
刊名:The Lancet Oncology
出版年:2016
2.
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
作者:
Dr Ian E Krop
;
MD
a
;
ian_krop@dfci.harvard.edu" class="auth_mail" title="E-mail the corresponding author
;
Ingrid A Mayer
;
MD
b
;
Vinod Ganju
;
FRACP
c
;
Maura Dickler
;
MD
d
;
Stephen Johnston
;
MD
e
;
Serafin Morales
;
MD
f
;
Denise A Yardley
;
MD
g
;
Prof
Bohuslav
Melichar
;
MD
h
;
Andres Forero-Torres
;
MD
i
;
Soo Chin Lee
;
MRCP
j
;
Richard de Boer
;
FRACP
k
;
Katarina Petrakova
;
PhD
l
;
Susanne Vallentin
;
MD
m
;
Edith A Perez
;
MD
n
;
Prof Martine Piccart
;
PhD
o
;
Prof Matthew Ellis
;
MD
p
;
Prof Eric Winer
;
MD
a
;
Steven Gendreau
;
PhD
q
;
Mika Derynck
;
MD
q
;
Mark Lackner
;
PhD
q
;
Gallia Levy
;
MD
q
;
Jiaheng Qiu
;
PhD
q
;
Jing He
;
MD
q
;
Prof Peter Schmid
;
MD
r
刊名:The Lancet Oncology
出版年:2016
3.
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
作者:
Dr Robert J Motzer
;
MD
a
;
motzerr@mskcc.org" class="auth_mail" title="E-mail the corresponding author
;
Thomas E Hutson
;
DO
b
;
Hilary Glen
;
MD
c
;
M Dror Michaelson
;
MD
d
;
Ana Molina
;
MD
e
;
Prof Timothy Eisen
;
FRCP
f
;
Prof Jacek Jassem
;
MD
g
;
Jakub Zolnierek
;
MD
h
;
Jose Pablo Maroto
;
MD
i
;
Begoñ
;
a Mellado
;
MD
j
;
Prof
Bohuslav
Melichar
;
MD
k
;
Jiri Tomasek
;
MD
l
;
Alton Kremer
;
MD
m
;
Han-Joo Kim
;
PhD
m
;
Karen Wood
;
PhD
n
;
Corina Dutcus
;
MD
m
;
James Larkin
;
FRCP
o
刊名:The Lancet Oncology
出版年:2015
4.
Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines
作者:
Alexandr Poprach
;
M.D.
;
Ph.D
a
;
Tomas Pavlik
;
Ph.D
b
;
Bohuslav
Melichar
;
M.D.
;
Ph.D
c
;
Katerina Kubackova
;
M.D.
d
;
Zbynek Bortlicek
;
Ph.D.
b
;
Marek Svoboda
;
M.D.
;
Ph.D.
a
;
Radek Lakomy
;
M.D.
;
Ph.D.
a
;
Rostislav Vyzula
;
M.D.
;
Ph.D.
a
;
Igor Kiss
;
M.D.
;
Ph.D.
a
;
Ladislav Dusek
;
Ph.D.
b
;
Tomas Buchler
;
M.D.
;
Ph.D.
e
;
tomas.buchler@ftn.cz" class="auth_mail
;
Czech Renal Cancer Cooperative Group
关键词:
renal cell carcinoma
;
prognosis
;
survival
;
sunitinib
;
sorafenib
刊名:Urologic Oncology: Seminars and Original Investigations
出版年:May 2014
5.
Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis
作者:
Tomas Buchler
;
M.D.
;
Ph.D.
a
;
tomas.buchler@ftn.cz" class="auth_mail
;
Zbynek Bortlicek
;
Ph.D.
b
;
Alexandr Poprach
;
M.D.
;
Ph.D.
c
;
Katerina Kubackova
;
M.D.
d
;
Igor Kiss
;
M.D.
;
Ph.D.
c
;
Milada Zemanova
;
M.D.
;
Ph.D.
e
;
Ondrej Fiala
;
M.D.
f
;
Ladislav Dusek
;
Ph.D.
b
;
Rostislav Vyzula
;
M.D.
;
Ph.D.
c
;
Bohuslav
Melichar
;
M.D.
;
Ph.D.
g
;
on behalf of the Czech Renal Cancer Cooperative Group
关键词:
Everolimus
;
mTOR
;
Renal cell carcinoma
;
Tyrosine kinase inhibitors
;
Therapy
刊名:Urologic Oncology: Seminars and Original Investigations
出版年:July 2014
6.
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
作者:
Dr Prof Robert J Motzer
;
MD
a
;
motzerr@mskcc.org" class="auth_mail
;
Camillo Porta
;
MD
b
;
Prof Nicholas J Vogelzang
;
MD
c
;
Cora N Sternberg
;
MD
d
;
Prof Cezary Szczylik
;
MD
e
;
Jakub Zolnierek
;
MD
f
;
Christian Kollmannsberger
;
MD
g
;
Sun Young Rha
;
MD
h
;
Georg A Bjarnason
;
MD
i
;
Prof
Bohuslav
Melichar
;
MD
j
;
Ugo De Giorgi
;
MD
k
;
Prof Viktor Grü
;
nwald
;
MD
l
;
Ian D Davis
;
MBBS
m
;
Prof Jae-Lyun Lee
;
MD
n
;
Prof Emilio Esteban
;
MD
o
;
Gladys Urbanowitz
;
MBA
p
;
Can Cai
;
PhD
p
;
Matthew Squires
;
PhD
q
;
Mahtab Marker
;
PhD
p
;
Michael M Shi
;
MD
p
;
Prof Bernard Escudier
;
MD
r
刊名:Lancet Oncology
出版年:March, 2014
7.
Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study
作者:
Mario Campone
;
Thomas Bachelot
;
Michael Gnant
;
Ines Deleu
;
Hope S. Rugo
;
Barbara Pistilli
;
Shinzaburo Noguchi
;
Mikhail Shtivelb
;
Kathleen I. Pritchard
;
Louise Provencher
;
Howard A. Burris III
;
Lowell Hart
;
Bohuslav
Melichar
;
Gabriel N. Hortobagyi
;
Francis Arena
;
Jos¨¦ Baselga
;
Ashok Panneerselvam
;
Aurelia H¨¦niquez
;
Mona El-Hashimyt
;
Tetiana Taran
;
et al.
关键词:
Advanced breast cancer
;
Everolimus
;
Exemestane
;
Visceral metastases
刊名:European Journal of Cancer
出版年:2013
8.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial
作者:
Prof Istvan Lang
;
MD
a
;
Thomas Brodowicz
;
MD
b
;
Larisa Ryvo
;
MD
c
;
Prof Zsuzsanna Kahan
;
MD
d
;
Prof Richard Greil
;
MD
e
;
Semir Beslija
;
MD
f
;
Salomon M Stemmer
;
MD
g
;
Bella Kaufman
;
MD
h
;
Zanete Zvirbule
;
MD
i
;
Gü
;
nther G Steger
;
MD
b
;
Prof
Bohuslav
Melichar
;
MD
j
;
Tadeusz Pienkowski
;
MD
k
;
Daniela Sirbu
;
MD
l
;
Diethelm Messinger
;
MSc
m
;
Prof Christoph Zielinski
;
MD
b
;
christoph.zielinski@meduniwien.ac.at
;
on behalf of the Central European Cooperative Oncology Group
&dagger
;
刊名:Lancet Oncology
出版年:2013
9.
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
作者:
Brian I Rini
;
Bohuslav
Melichar
;
Takeshi Ueda
;
Viktor Gr眉nwald
;
Mayer N Fishman
;
Jos茅 A Arranz
;
Angel H Bair
;
Yazdi K Pithavala
;
Glen I Andrews
;
Dmitri Pavlov
;
Sinil Kim
;
Eric Jonasch
刊名:Lancet Oncology
出版年:November, 2013
10.
PrefHer: finally addressing the preferences of her, too
作者:
Bohuslav
Melichar
刊名:Lancet Oncology
出版年:2013
1
2
3
按检索点细分(25)
作者(25)
按出版年细分(25)
2027年及以后(5)
2016年(2)
2015年(1)
2013年(3)
2012年(1)
2010年(4)
2008年(2)
2007年(1)
2006年(1)
2004年(2)
2003年(1)
2001年(1)
2000年及以前(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.